Cilnidipine clinical trials
Also written Cinalong.
How each study uses cilnidipine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 2
Boryung Pharmaceutical Co., Ltd (2) · IlDong Pharmaceutical Co Ltd (1) · Ministry of Health, Labour and Welfare, Japan (1) · Kyorin University (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Calcium channel blockers source
Studies
Open first, then newest update. How each study uses cilnidipine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and ValsartanCompletedPhase 1IlDong Pharmaceutical Co LtdNCT02343250Written as Cilnidipine/ValsartanHow we know
- Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)Status unknownPhase 2Ministry of Health, Labour and Welfare, JapanNCT00890279Written as CilnidipineHow we know
- Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With HypertensionCompletedPhase 3Boryung Pharmaceutical Co., LtdNCT00325637Written as cilnidipineHow we know
- The Effects of Cilnidipine on Metabolic Syndrome ImprovementCompletedPhase 4Boryung Pharmaceutical Co., LtdNCT00325936Written as CilnidipineHow we know
- CCB Safety Study in Treatment of Hypertension of ADPKDStatus unknownPhase 4Kyorin UniversityNCT00541853Written as Candesartan and CilnidipineHow we know
Codes
What other systems call cilnidipine · ClinicalTrials.gg INT003533
- MeSH (NLM) C065927cilnidipineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 97T5AZ1JIPCILNIDIPINEConfirmed FDA, NLM, Wikidata
- Wikidata Q731525cilnidipineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171754CilnidipineOne source FDA
- DrugBank DB09232One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C065927 | cilnidipine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 97T5AZ1JIP | CILNIDIPINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q731525 | cilnidipine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171754 | Cilnidipine | One source FDA |
| DrugBank | DB09232 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.